53 related articles for article (PubMed ID: 32361033)
41. Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients.
Trentini F; Mazzaschi G; Milanese G; Pavone C; Madeddu D; Gnetti L; Frati C; Lorusso B; Lagrasta CAM; Minari R; Ampollini L; Ledda RE; Silva M; Sverzellati N; Quaini F; Roti G; Tiseo M
Tumori; 2022 Feb; 108(1):86-92. PubMed ID: 33730957
[TBL] [Abstract][Full Text] [Related]
42. Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer.
Mazzaschi G; Milanese G; Pagano P; Madeddu D; Gnetti L; Trentini F; Falco A; Frati C; Lorusso B; Lagrasta C; Minari R; Ampollini L; Silva M; Sverzellati N; Quaini F; Roti G; Tiseo M
Data Brief; 2020 Aug; 31():105781. PubMed ID: 32548224
[TBL] [Abstract][Full Text] [Related]
43. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
44. Low PD-1 Expression in Cytotoxic CD8
Mazzaschi G; Madeddu D; Falco A; Bocchialini G; Goldoni M; Sogni F; Armani G; Lagrasta CA; Lorusso B; Mangiaracina C; Vilella R; Frati C; Alfieri R; Ampollini L; Veneziani M; Silini EM; Ardizzoni A; Urbanek K; Aversa F; Quaini F; Tiseo M
Clin Cancer Res; 2018 Jan; 24(2):407-419. PubMed ID: 29074606
[No Abstract] [Full Text] [Related]
45. Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer.
Bocchialini G; Lagrasta C; Madeddu D; Mazzaschi G; Marturano D; Sogni F; Silini EM; Gnetti L; Becchi G; Rusca M; Carbognani P; Ventura L; Braggio C; Tiseo M; Quaini F; Ampollini L
Eur J Cardiothorac Surg; 2020 Sep; 58(3):619-628. PubMed ID: 32267920
[TBL] [Abstract][Full Text] [Related]
46. Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC.
Mazzaschi G; Milanese G; Pagano P; Madeddu D; Gnetti L; Trentini F; Falco A; Frati C; Lorusso B; Lagrasta C; Minari R; Ampollini L; Silva M; Sverzellati N; Quaini F; Roti G; Tiseo M
Lung Cancer; 2020 Jun; 144():30-39. PubMed ID: 32361033
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
Liu J; Dong M; Sun X; Li W; Xing L; Yu J
PLoS One; 2016; 11(1):e0146195. PubMed ID: 26727114
[TBL] [Abstract][Full Text] [Related]
48. Radiomics features as predictive and prognostic biomarkers in NSCLC.
Bortolotto C; Lancia A; Stelitano C; Montesano M; Merizzoli E; Agustoni F; Stella G; Preda L; Filippi AR
Expert Rev Anticancer Ther; 2021 Mar; 21(3):257-266. PubMed ID: 33216651
[No Abstract] [Full Text] [Related]
49. Radiomic Signatures Associated with CD8
Ramlee S; Hulse D; Bernatowicz K; Pérez-López R; Sala E; Aloj L
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954318
[TBL] [Abstract][Full Text] [Related]
50.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
